GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.05G165300	P31492	4-[(E)-2-(7-Heptoxy-4,4-dimethyl-1,1-dioxo-2,3-dihydrothiochromen-6-yl)prop-1-enyl]benzoic acid	2	1.48958155664158e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P00752	5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine	1	9.39742261763576e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P02658	5,7,3',4',5'-Pentahydroxyflavanone	1	1.70529740069553e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P03852	1-O-Galloylglycerol	1	4.89265110819168e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P03945	6-Hydroxytricetin 5-glucoside	1	1.08978697089794e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P03953	3,3'-Bisanigorufone	1	1.31724716838238e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P04074	(+)-Indocarbazostatin	1	5.38808845527943e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P04154	(+)-SQ 26517	1	4.65853713966606e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P05986	Acrinol	1	9.23716691197704e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P06786		1	9.6333370629293e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P08067	Fulvic acid	1	2.29879961272707e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P08205		1	8.30678642492608e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P08233	4''-O-Acetylmananthoside B	1	5.23678841699272e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P08394		1	6.66928360409792e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P08490	Torokonine	1	8.92089770791147e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P09087		1	8.03919114898236e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P14924		1	1.17418686275426e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P15158	N-Nitrosohydroxyproline	1	4.53664144213075e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P15537	Methyl 3,4,6-tri-O-galloyl-beta-D-glucopyranoside	1	2.55558175723838e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P16934		1	3.10121649615975e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P17220	Albiproflavone	1	1.14559615774786e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P17556	Ganomastenol C	1	8.43931086900305e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P18094		1	4.62374971101275e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P18605	alpha-Calacorene	1	4.16133097555691e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P19794	Caudoxirene	1	5.74107054344123e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P20634	Euphoscopin F	1	8.9801600016709e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P22618	(Z)-3-Hexenyl 3-methylbutanoate	1	7.21213062744319e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P23903		1	4.63604576039619e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P23909		1	4.33629435454664e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P24096	2-[Hydroxy(phenyl)methyl]phenol	1	1.24310373794763e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P24270	Lasiandrin	1	3.65622192754491e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P25648	Triamcinolone hexacetonide	1	6.29674523219746e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P25741	MG(0:0/5-iso PGF2VI/0:0)	1	5.86828657571905e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P26171	Formosanatin B	1	6.81955210999293e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P26996		1	2.06001621096144e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P28118		1	2.37801498134873e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P28273		1	2.04172927787107e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P28312	alpha-Curcumene	1	7.05353792972542e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P28419	Glutamylleucylarginine	1	9.36177913148295e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P31729	3-((2'-(Benzoylaminosulfonyl)biphenyl-4-yl)methyl)-2-ethyl-5,7-dimethyl-3H-imidazo(4,5-b)pyridine	1	6.5845733205601e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P31940	Marsupellol acetate	1	3.3381454192774e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P32815		1	5.73883228010163e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P33262	(R*,S*)-4-[1-Ethyl-2-(4-fluorophenyl)butyl]phenol	1	1.29552040594945e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P34345	Tulipalin A	1	5.96272844284998e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P35790		1	6.87282125577987e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P36114	Cryptostigmin III	1	7.66952789854372e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P37547	4-Hydroxy-2-oxohexanoic acid	1	2.84775120355376e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P37598		1	9.7585588591561e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P37799	4-pregnene-17alpha,20beta,21-triol-3,11-dione	1	8.68824370752484e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P38167		1	4.25148689495827e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P38526		1	8.41626453875685e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P39433	3'-Hydroxy T-2 toxin	1	1.03833225523613e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P41051	(3E,5Z)-1,3,5-Heptatriene	1	4.81873833433913e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P41829	Renieramycin R	1	7.91069641028265e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P43199	Adouetine Z	1	3.26641060036518e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P43317	Mutant IDH1 inhibitor	1	1.84723268018147e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P44113		1	6.76183668127084e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P45290	ent-19-Acetoxy-14,15,16-trihydroxymanoyl oxide	1	2.78130096688253e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P45690	PC(6 keto-PGF1alpha/16:1(9Z))	1	2.29859545693366e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P46154	N-decanoyl-histidine	1	1.55674183710195e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P46897	Leupeptin	1	1.60489638072895e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P47142	4'-(beta-D-Glucopyranosyloxy)-7',8'-dihydro-4,4'-diapo-psi,psi-caroten-4-oic acid	1	7.5853530333146e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P47437	Montelukast	1	7.84742693379012e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P47544	Ancorinoside C	1	6.91924652786724e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P49066	3'-Hydroxy-3,4,4',5-tetramethoxybibenzyl	1	7.79943019085378e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P49383	Alangiobussinine	1	6.00752638650012e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P49915	(6Z,8Z)-Hexadeca-6,8-dienedioylcarnitine	1	1.54049954184969e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P50938	5,7-octadienoic acid	1	3.10003482873412e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P51034	2-Iminobutanoate	1	9.19192834912233e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P51572	Lactapiperanol C	1	1.15518988858767e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P51817		1	1.26854111359008e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P52235	Carindone	1	2.67537147110649e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P53515	1,2-Dimethyl-4-(6-methyl-4-heptenyl)-1,3-cyclohexadiene	1	8.89670653633046e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P54087	Ilicifolioside B	1	2.98899631905567e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P55173	2-Chloro-3-hydroxy-7-chamigren-9-one	1	7.02027389566729e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P55336		1	9.57999020945268e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.05G165300	P55391		1	2.58423991604447e-12	overlap	1e-10	<	Wm82.a2.v1